What is the name of the vaccine for dogs against ticks? - briefly
«Vanguard» is the commercial name of the canine vaccine that protects against Lyme disease transmitted by ticks. It induces immunity to Borrelia burgdorferi, the bacterium responsible for the infection.
What is the name of the vaccine for dogs against ticks? - in detail
The canine vaccine specifically targeting tick‑borne disease is marketed under the name «Nobivac Lyme» (also available as «Recombitek Lyme»). It is a recombinant subunit vaccine that contains the outer‑surface protein A (OspA) of Borrelia burgdorferi, the bacterium responsible for Lyme disease transmitted by ticks.
The vaccine formulation consists of purified OspA antigen combined with an aluminum‑hydroxide adjuvant to enhance immune response. Each dose delivers a standardized amount of antigen, ensuring consistent protection across administrations.
Recommended immunisation protocol:
- Initial series: two injections given three to four weeks apart.
- Booster: a single injection twelve months after the second dose.
- Annual revaccination thereafter to maintain immunity.
Clinical studies report efficacy rates between 80 % and 95 % in preventing clinical Lyme disease when the full schedule is followed. Protection primarily covers infection by the most prevalent B. burgdorferi genospecies in North America and Europe.
Safety data indicate mild, transient reactions such as localized swelling, mild fever, or reduced appetite. Severe adverse events are rare; contraindications include hypersensitivity to any vaccine component and administration to pregnant or lactating dogs without veterinary assessment.
Regulatory bodies (e.g., USDA, EMA) have approved the product for use in dogs older than eight weeks. The vaccine is distributed through veterinary clinics and authorized pet‑care retailers in regions where tick exposure poses a significant health risk.